Focusing on Biologics and Peptide Drugs, Driving a Healthy Future
DesigneRx Pharmaceuticals(Chengdu), Inc. – Safeguarding Human Life and Health with Innovative Technology and Intelligent Manufacturing
Synthetic Biology Leads the Future
‧
Intelligent Manufacturing Safeguards Health
Founded in 2013 and located in the Chengdu Hi-Tech Industrial Development Zone, DesigneRx Pharmaceuticals(Chengdu), Inc., it is affiliated to Polaris Group. The company specializes in the R&D and manufacturing of biologics and peptide drugs. We have established a modern GMP facility compliant with FDA, EMA, and NMPA standards, covering an area of 45,000 m² with a built-up area of approximately 30,000 m².
From Sequence to Finished Product,End-to-End Peptide and Biologics Solutions
From R&D to Commercialization, Providing Efficient and Compliant Full-cycle Support for Pharmaceutical Companies Worldwide
DesigneRx Pharmaceuticals provides comprehensive solutions from amino acid sequence design to Active Pharmaceutical Ingredient (API) and commercialization. Our production capacity ranges from mg-scale to kg-scale, encompassing lab-scale, pilot-scale, process validation, and commercial batches. Execution strictly under international and domestic GMP guidelines ensuring product stability and compliance.
Our production system encompasses key processes such as bio-fermentation, purification, and chemical synthesis, with kilogram-scale (up to 100Kg) peptide production capacity.
10000kg
We provide full-cycle production support from clinical samples to commercial products. Based on the principles of molecular biology, our R&D platform covers core aspects including process development, analytical research, and formulation development, forming integrated capabilities from lab-scale, pilot-scale to commercial production.
Supported by the global resources of Polaris Group, DesigneRx Pharmaceuticals fully aligns its R&D, quality management, and information security with international standards, continuously enhancing our core competitiveness in the field of synthetic peptides and biological formulations, and is committed to becoming a world-renowned pharmaceutical enterprise.
Intelligent Manufacturing‧Green Technology‧Global Standards
World-leading Biopharmaceutical Manufacturing and Testing Facilities
The Chengdu site features 30,000m2of modern R&D and GMP production facilities, including sterile formulation workshops with liquid and lyophilized formulation production lines, compliant with FDA, EMA, and NMPA GMP regulations. The formulation production workshop utilizes fully automatic sterile filling, enabling full-cycle data traceability and environmental control.
Empowering Innovation with Science,Safeguarding Life with Quality
Join Hands with DesigneRx to Co-create the Future of Innovative Medicine
DesigneRx Pharmaceuticals is committed to partnering with global collaborators to advance the innovative R&D and production of biologics and peptide drugs. With science as our belief and quality as our foundation, let’s build a sustainable future for medicine together.
| Address | No.198, Tiansheng Road, Hi-Tech Zone, Chengdu City, 611731, China |
|---|---|
| TEL | 86-28-87927676 ext.826 |
| business@polarispharma.com | |
| Official Website | https://polarispharma.com |
